Key Metrics
CiteScore 

6.6
Eigenfactor 

0.05 - 0.1
Impact Factor 

5 - 10
Scite Index 

0.91 5-Year SI

SJR 

Q1Pharmacology

SNIP 

1.39
Recommended pre-submission checks
Powered by 

Topics Covered on Frontiers in Pharmacology
Frontiers in Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
SJR
| Overview | |
| Publisher | FRONTIERS MEDIA SA |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2950 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Frontiers in Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Frontiers in Pharmacology
Immune-related adverse reactions across multiple systems in a non-small cell lung cancer patient induced by immune checkpoint inhibitors: a case report and literature review
- 23 Oct 2026
- Frontiers in Pharmacology
ABT score based clinical model predicts prognosis in unresectable hepatocellular carcinoma treated with TACE combined with bevacizumab and sintilimab therapy
- 23 Oct 2026
- Frontiers in Pharmacology
Cotinus coggygria Scop. extract-loaded polycaprolactone/hyaluronic acid nanofibers as candidate wound dressings: in vitro characterization, cytocompatibility and antibacterial evaluation
- 23 Oct 2026
- Frontiers in Pharmacology
Safety profiles of current and emerging neoadjuvant immune-modulatory and combination strategies in borderline resectable stage III non-small cell lung cancer: a narrative review
- 23 Oct 2026
- Frontiers in Pharmacology
The impact of GLP-1 receptor agonists on chemotherapeutic efficacy: insights from GWAS and experiments
- 23 Oct 2026
- Frontiers in Pharmacology
Engineered hyalurosomal gel co-delivering citicoline sodium and nifedipine for potential glaucoma management: formulation and pharmacodynamic evaluation
- 23 Oct 2026
- Frontiers in Pharmacology
Immune-related adverse reactions across multiple systems in a non-small cell lung cancer patient induced by immune checkpoint inhibitors: a case report and literature review
- 23 Oct 2026
- Frontiers in Pharmacology
ABT score based clinical model predicts prognosis in unresectable hepatocellular carcinoma treated with TACE combined with bevacizumab and sintilimab therapy
- 23 Oct 2026
- Frontiers in Pharmacology
Cotinus coggygria Scop. extract-loaded polycaprolactone/hyaluronic acid nanofibers as candidate wound dressings: in vitro characterization, cytocompatibility and antibacterial evaluation
- 23 Oct 2026
- Frontiers in Pharmacology
Safety profiles of current and emerging neoadjuvant immune-modulatory and combination strategies in borderline resectable stage III non-small cell lung cancer: a narrative review
- 23 Oct 2026
- Frontiers in Pharmacology
The impact of GLP-1 receptor agonists on chemotherapeutic efficacy: insights from GWAS and experiments
- 23 Oct 2026
- Frontiers in Pharmacology
Engineered hyalurosomal gel co-delivering citicoline sodium and nifedipine for potential glaucoma management: formulation and pharmacodynamic evaluation
- 23 Oct 2026
- Frontiers in Pharmacology